934182-73-7

Usage

Uses

Used in Pharmaceutical Synthesis:
N-Benzyl-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol is used as a chiral building block for the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic benefits.
Used in Organic Chemistry:
In the field of organic chemistry, N-Benzyl-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol serves as a versatile intermediate, facilitating the creation of complex organic molecules and contributing to advancements in chemical research and compound development.
Due to the compound's intricate structure, it necessitates careful handling and the application of precise synthesis techniques within a laboratory environment to fully harness its potential in these applications.

Upstream product

• 77716-01-9 7-benzyl-3-oxa-7-azabicyclo<3.3.1>nonan-9-one 
• 29943-42-8 Tetrahydro-4H-pyran-4-one 
• 100-46-9 benzylamine 
• 1254360-59-2 7-benzyl-3-oxa-7-azabicyclo[3.3.1]nonan-9-one hydrochloride 

Downstream Products

• 1246187-79-0 3-oxa-7-azabicyclo[3.3.1]nonan-9-ol 
• 1147557-68-3 tert-butyl 9-hydroxy-3-oxa-7-azabicyclo[3.3.1]nonane-7-carboxylate 

Relevant academic research and scientific papers

THERAPEUTICALLY ACTIVE BICYCLIC-SULPHONAMIDES AND PHARMACEUTICAL COMPOSITIONS

Pharmaceutical compounds have a bicyclic-sulphonamide structure and pharmaceutical compositions including the compounds may be used in therapy as brain-cell-death protectants and may be used, for example, in the treatment of chronic neurodegenerative diseases. The compounds are active as inhibitors of N-acylethanolamine-hydrolysing acid amidase (NAAA) and may be used for the therapeutic treatment and prevention of pain and inflammatory disorders and other disorders which benefit from the modulation of fatty acid ethanolamides, particularly palmitoylethanolamide (PEA).

IMIDAZO-PYRAZOLES AS GPR119 INHIBITORS

Compounds of formula (I) wherein: X is (A) or (B); Y is O or a bond; R1 is -C(O)-O-R3 or R2 is hydrogen, cyano, C1-C6 alkyl, or C3-C6 cycloalkyl; R5 is hydrogen, cyano

3-OXA-7-AZABICYCLO[3.3.1]NONANES

Compounds of Formula (I) that modulate the activity of the G-protein-coupled receptor GPR119 and their uses in the treatment of diseases linked to the modulation of the G-protein-coupled receptor GPR119 in animals are described herein.

GPR 119 MODULATORS

Compounds of Formula (I) that modulate the activity of the G -protein-coupled receptor GPFM 19 and their uses in the treatment of diseases linked to the modulation of the G-protein-coupled receptor GPR119 in animals are described herein.

BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS

The present invention relates to Bicyclic Heterocycle Derivatives of Formula (I), compositions comprising a Bicyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a metaboli